Skip to main content
SpringerLink
Log in

Role of Otoacoustic Emission in Early Detection of Cisplatin Induced Ototoxicity

  • Original Article
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

Cisplatin is a chemotherapeutic agent effective against head and neck carcinoma but unfortunately it is cochleotoxic. This study has been designed to investigate the efficacy of OAE in identifying early effects of cisplatin on the cochlea and the importance of protocol for audiological monitoring of cisplatin induced ototoxicity. This is a prospective observational study conducted from October 2012 to September 2014 on 70 patients, receiving Cisplatin for various malignant conditions. Audiological criteria for ototoxicity was considered as a difference of 10 d B or more in pure tone thresholds of two or more adjacent frequencies in conventional audiometry and in DPOAE-Signal noise ratio less than 6 dB or DPOAE amplitude less than 20 dBSPL (irrespective of SNR > 6 dB). According to PTA, 60.7% patients showed ototoxicity after completion of chemotherapy. In DPOAE, according to SNR and amplitude criteria more than 60% patients showed ototoxicity after first cycle of cisplatin at high frequencies (4–8 kHz). DPOAEs is a sensitive tool for early detection of ototoxicity and protocol is necessary for monitoring ototoxicity in patients receiving cisplatin to improve the quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gray RF, Hawthorne M (1992) Synopsis of otolaryngology, 5th edn. Butterworth Heinemann, Oxford, p 160

    Google Scholar 

  2. Sharma VM, Wilson WR (1999) Radiosensitization of advanced squamous cell carcinoma of the head and neck with cisplatin during concomitant radiation therapy. Eur Arch Otorhinolaryngol 256(9):462–465

    Article  CAS  Google Scholar 

  3. Stavroulaki P, Apostolopoulos N, Segas J, Tsukanikos M (2001) Evoked Otoacoustic emission-an approach for monitoring cisplatin induced Ototoxicity in children. Int J Pediatric Otorhinolaryngol 59(1):47–57

    Article  CAS  Google Scholar 

  4. Pratt Hillel (2008) Evoked physiological measurement of auditory sensitivity. In: Brown Scott (ed) Otorhinolaryngology, Head and neck Surgery, 7th edn. Edward Arnold (Publishers) Ltd, London, pp 3276–97

    Google Scholar 

  5. ASHA (1994) Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. Asha 36(Suppl. 12):11–19

    Google Scholar 

  6. Peyrone M (2006) UeberdieEinwirkung des Ammoniaks auf Platinchlorur. Ann Chemie Pharm 51:1–29

    Article  Google Scholar 

  7. Rybak LP, Whitworth CA (2005) Ototoxicity therapeutic opportunities. Drug Discovery Today 10:1313–1321

    Article  CAS  Google Scholar 

  8. Anniko N, Sobin A (1986) Cisplatin: Evaluation of its ototoxic potential. Am J Otolaryngol 7:276–293

    Article  CAS  Google Scholar 

  9. Sha SH, Taylor R, Forge A, Schacht J (2001) Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res 155:1–8

    Article  CAS  Google Scholar 

  10. O’Leary Stephen (2008) Ototoxicity. In: Kerr AG (ed) Scott Brown otorhinolaryngology, head and neck surgery, 7th edn. Edward Arnold Ltd, London, pp 3567–3576

    Chapter  Google Scholar 

  11. Vermorken JB, Kapteijn TS, Hart AA et al (1983) Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration. Eur J Cancer ClinOncol 1:53–58

    Article  Google Scholar 

  12. Komune S, Asakuma S, Snow JB Jr (1981) Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum. Otolaryngol Head Neck Surg 89:275–282

    Article  CAS  Google Scholar 

  13. Blakley BW, Gupta AK, Myers SF et al (1994) Risk factors for ototoxicity due to cisplatin. Arch Otolaryngol Head Neck Surg 120(5):541–546

    Article  CAS  Google Scholar 

  14. Wright A, Forge A, Kotecha A (1997) In: Kerr AG (ed) Scott brown otolaryngology, 6th edn. Bath Press, London

    Google Scholar 

  15. Campbell KC, Durrant J (1993) Audiologic monitoring for ototoxicity. OtolaryngolClin North Am 26:903–914

    Article  CAS  Google Scholar 

  16. Kemp DT (1986) Otoacousticemissions, travellingwaves, and cochlear mechanisms. Hear Res 22:95–104

    Article  CAS  Google Scholar 

  17. Kim DO (1980) Cochlear mechanics: implications of electrophysiological and acoustical observations. Hear Res 2(3–4):297–317

    Article  CAS  Google Scholar 

  18. Hallmark RJ, Snyder JM, Jusenius K, Tamimi HK (1992) Factors influencing ototoxicity in ovarian cancer patients treated with Cis-platinum based chemotherapy. Eur J GynaecolOncol 13(1):35–44

    CAS  Google Scholar 

  19. Plinkert PK, Kröber S (1991) Laryngorhinootologie 70(9):457–462

    Article  CAS  Google Scholar 

  20. Orts AM, Garcia CJ, Morant VA, Esparcia FBF, Marco NM, Algarra J (2000) Clinical study on the ototoxicity of cisplatin with distortion products. Acta Otorrinolaringol Esp 51(6):469–77

    Google Scholar 

  21. Biro K, Noszek L, Prekopp P, Nagyivanyi K, Geczi L, Gaudi I, Bodrogi I (2006) Characteristics and risk factors of cisplatin induced ototoxicity in testicular cancer patients detected by DOOAE. Oncology 70(3):177–184

    Article  CAS  Google Scholar 

Download references

Funding

This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

Author information

Author notes

  1. Shama Shetty

    Present address: Department of ENT, Kasturba Medical College, Manipal, India

Authors and Affiliations

  1. Department of ENT, KSHEMA, Mangalore, India

    Shama Shetty, Satheesh Kumar Bhandary, Vadisha Bhat, Rajeshwary Aroor & Jayarama Shetty

  2. Nitte Institute of Speech and Hearing, Mangalore, India

    T. Dattatreya

Authors
  1. Shama Shetty
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satheesh Kumar Bhandary
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vadisha Bhat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rajeshwary Aroor
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jayarama Shetty
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. Dattatreya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shama Shetty.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Statement

Ethics committee approval has been obtained from Institutional ethics committee for the study.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shetty, S., Bhandary, S.K., Bhat, V. et al. Role of Otoacoustic Emission in Early Detection of Cisplatin Induced Ototoxicity. Indian J Otolaryngol Head Neck Surg 74 (Suppl 1), 164–169 (2022). https://doi.org/10.1007/s12070-020-01933-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-020-01933-7

Keywords

Search

Navigation